Comparison of depot tetracosactrin and corticotrophin gel.
Depot tetracosactrin has been compared with corticotrophin gel in 12 inpatients of a rheumatic diseases unit Every patient received one subcutaneous infection each of the synthetic and the animal preparation, with serial measurements of plasma 11-hydroxycorticosteroids, 12-hourly urinary 11-hydroxycorticosteroids, and 17-oxogenic steroids. The duration of action of the depot tetracosactrin was virtually twice that of corticotrophin gel, the dose relationship being about 0.25 mg. of depot tetracosactrin to 50 units of gel. Local reaction to the injection of depot tetracosactrin was relatively frequent.
D015068:17-Ketosteroids / Q000652:urine; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage*; D000368:Aged; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005260:Female; D005782:Gels; D005938:Glucocorticoids / Q000097:blood / Q000652:urine; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage; D012216:Rheumatic Diseases / Q000188:drug therapy
D015068:17-Ketosteroids; D003692:Delayed-Action Preparations; D005782:Gels; D005938:Glucocorticoids; D010455:Peptides; D000324:Adrenocorticotropic Hormone